Fan Yu
- Topics
- MicroRNA in disease regulation (3 papers)Reproductive System and Pregnancy (3 papers)Cancer-related molecular mechanisms research (3 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaScientific Reports
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Fan Yu
50 papers receiving 568 citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Molecular Biology 199
- Cancer Research 85
- Pulmonary and Respiratory Medicine 79
- Surgery 61
- Epidemiology 57
Countries citing papers authored by Fan Yu
This map shows the geographic impact of Fan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fan Yu more than expected).
Fields of papers citing papers by Fan Yu
This network shows the impact of papers produced by Fan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fan Yu. The network helps show where Fan Yu may publish in the future.
Co-authorship network of co-authors of Fan Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Fan Yu. A scholar is included among the top collaborators of Fan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fan Yu. Fan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021breakdown → | 59 |
| 7 | 2 | |
| 8 | 18 | |
| 9 | 0 | |
| 10 | 18 | |
| 11 | 17 | |
| 12 | 16 | |
| 13 | 0 | |
| 14 | 17 | |
| 15 | 19 | |
| 16 | Clinical Analysis of Risk Factors for Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 3686 Patients | 2 |
| 17 | 17 | |
| 18 | 25 | |
| 19 | Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients | 4 |
| 20 | 1 |
About Fan Yu
Fan Yu is a scholar working on Obstetrics and Gynecology, Cancer Research and Reproductive Medicine, having authored 61 papers that have together received 575 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Reproductive System and Pregnancy (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Obstetrics and Gynecology (46 citations), Cancer Research (85 citations) and Complementary and alternative medicine (35 citations). Fan Yu has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Lijia Xu, Peigen Xiao, Zhixiang Xu, Qinghua Tang, Xuguang Qiao, Yanxin Wu, Minghui Cao, Mian He, Shuzhong Yao and Haihong He. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.